The molecular neurobiology of depression

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Nature

• Publication date

  2008-10-15

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1038/nature07455PMID 18923511PMCID PMC2721780
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• When not enough is too much: the role of insufficient glucocorticoid signaling in the pathophysiology of stress-related disorders.

  2011cited by this paper
• Polymorphisms in the drug transporter gene ABCB1 predict antidepressant treatment response in depression.

  2008cited by this paper
• Deep Brain Stimulation to Reward Circuitry Alleviates Anhedonia in Refractory Major Depression

  2008cited by this paper
• The orexigenic hormone ghrelin defends against depressive symptoms of chronic stress

  2008cited by this paper
• Acute administration of ketamine induces antidepressant-like effects in the forced swimming test and increases BDNF levels in the rat hippocampus.

  2008cited by this paper
• Stress, Depression, and Neuroplasticity: A Convergence of Mechanisms

  2008cited by this paper
• Cellular mechanisms underlying the antidepressant effects of ketamine: role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors.

  2008cited by this paper
• Glucocorticoid antagonists in neuropsychiatric [corrected] disorders.

  2008cited by this paper
• REGIONALLY-SPECIFIC REGULATION OF pERK1/2 MAP KINASE IN A MODEL OF ANTIDEPRESSANT-SENSITIVE CHRONIC DEPRESSION

  2008cited by this paper
• Mechanisms and functional implications of adult neurogenesis.

  2008cited by this paper
• From inflammation to sickness and depression: when the immune system subjugates the brain

  2008cited by this paper
• Novel Drugs and Therapeutic Targets for Severe Mood Disorders

  2008cited by this paper
• Meta-analyses of genetic studies on major depressive disorder

  2008cited by this paper
• Evidence of biologic epistasis between BDNF and SLC6A4 and implications for depression

  2008cited by this paper
• Drug-dependent requirement of hippocampal neurogenesis in a model of depression and of antidepressant reversal.

  2008cited by this paper
• Neuropeptide Y in the Amygdala Induces Long-Term Resilience to Stress-Induced Reductions in Social Responses But Not Hypothalamic–Adrenal–Pituitary Axis Activity or Hyperthermia

  2008cited by this paper
• The neurogenic reserve hypothesis: what is adult hippocampal neurogenesis good for?

  2008cited by this paper
• Medical burden in late-life bipolar and major depressive disorders.

  2008cited by this paper
• IL-1β is an essential mediator of the antineurogenic and anhedonic effects of stress

  2008cited by this paper
• How can we realize the promise of personalized antidepressant medicines?

  2008cited by this paper
• VEGF is an essential mediator of the neurogenic and behavioral actions of antidepressants

  2007cited by this paper
• New insights into BDNF function in depression and anxiety

  2007cited by this paper
• Is it time to reassess the BDNF hypothesis of depression?

  2007cited by this paper
• Molecular studies of major depressive disorder: the epigenetic perspective

  2007cited by this paper
• Adult hippocampal neurogenesis in depression

  2007cited by this paper
• Emotion enhances learning via norepinephrine regulation of AMPA-receptor trafficking.

  2007cited by this paper
• Histone deacetylase 5 epigenetically controls behavioral adaptations to chronic emotional stimuli.

  2007cited by this paper
• Antidepressant-like effects of the histone deacetylase inhibitor, sodium butyrate, in the mouse.

  2007cited by this paper
• Serotonin(4) (5-HT(4)) receptor agonists are putative antidepressants with a rapid onset of action.

  2007cited by this paper
• Molecular adaptations underlying susceptibility and resistance to social defeat in brain reward regions.

  2007cited by this paper
• High-Speed Imaging Reveals Neurophysiological Links to Behavior in an Animal Model of Depression

  2007cited by this paper
• Physiology and neurobiology of stress and adaptation: central role of the brain.

  2007cited by this paper
• Antidepressant actions of the exercise-regulated gene VGF

  2007cited by this paper
• The Neuropeptide VGF Produces Antidepressant-Like Behavioral Effects and Enhances Proliferation in the Hippocampus

  2007cited by this paper
• Maternal care, the epigenome and phenotypic differences in behavior.

  2007cited by this paper
• Neurodevelopmental origins of depressive disorders.

  2007cited by this paper
• Limitations in efficacy of antidepressant monotherapy.

  2007cited by this paper
• The varied clinical presentations of major depressive disorder.

  2007cited by this paper
• Effectiveness of antipsychotic drugs in patients with chronic schizophrenia: efficacy, safety and cost outcomes of CATIE and other trials.

  2007cited by this paper
• Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial.

  2007cited by this paper
• Interactions between life stressors and susceptibility genes (5-HTTLPR and BDNF) on depression in Korean elders.

  2007cited by this paper
• About the American College of Neuropsychopharmacology

  2007cited by this paper
• Brain-Derived Neurotrophic Factor-5-HTTLPR Gene Interactions and Environmental Modifiers of Depression in Children

  2007cited by this paper
• The role of glutamate in mood disorders: Results from the ketamine in major depression study and the presumed cellular mechanism underlying its antidepressant effects

  2007cited by this paper
• Brain-derived neurotrophic factor conditional knockouts show gender differences in depression-related behaviors.

  2007cited by this paper
• Epigenetic regulation in psychiatric disorders

  2007cited by this paper
• Brain-derived neurotrophic factor Val66Met and psychiatric disorders: meta-analysis of case-control studies confirm association to substance-related disorders, eating disorders, and schizophrenia.

  2007cited by this paper
• 5-HT2A Receptor Activation Leads to Increased BDNF mRNA expression in C6 glioma cells

  2007cited by this paper
• A study of the involvement of melanin-concentrating hormone receptor 1 (MCHR1) in murine models of depression.

  2007cited by this paper
• Induction of deltaFosB in the periaqueductal gray by stress promotes active coping responses.

  2007cited by this paper
• Molecular Pathways Associated with Stress Resilience and Drug Resistance in the Chronic Mild Stress Rat Model of Depression—a Gene Expression Study

  2007cited by this paper
• Targeting abnormal neural circuits in mood and anxiety disorders: from the laboratory to the clinic

  2007cited by this paper
• Toward a comprehensive developmental model for major depression in men.

  2006cited by this paper
• Leptin: A potential novel antidepressant

  2006cited by this paper
• The mesolimbic dopamine reward circuit in depression.

  2006cited by this paper
• A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.

  2006cited by this paper
• New approaches to antidepressant drug discovery: beyond monoamines

  2006cited by this paper
• Genetic Variant BDNF (Val66Met) Polymorphism Alters Anxiety-Related Behavior

  2006cited by this paper
• Maternal care associated with methylation of the estrogen receptor-alpha1b promoter and estrogen receptor-alpha expression in the medial preoptic area of female offspring.

  2006cited by this paper
• Epigenetics and phenotypic variation in mammals

  2006cited by this paper
• Essential Role of BDNF in the Mesolimbic Dopamine Pathway in Social Defeat Stress

  2006cited by this paper
• TNFα Signaling in Depression and Anxiety: Behavioral Consequences of Individual Receptor Targeting

  2006cited by this paper
• Alterations in 5-HT1B Receptor Function by p11 in Depression-Like States

  2006cited by this paper
• A neurotrophic model for stress-related mood disorders.

  2006cited by this paper
• Depression as a risk factor for the onset of type 2 diabetes mellitus. A meta-analysis

  2006cited by this paper
• Brain-derived neurotrophic factor-5-HTTLPR gene interactions and environmental modifiers of depression in children.

  2006cited by this paper
• Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice.

  2006cited by this paper
• IL-6 knockout mice exhibit resistance to stress-induced development of depression-like behaviors.

  2006cited by this paper
• Comment on: Knol MJ, Twisk JWR, Beekman ATF, Heine RJ, Snoek FJ, Pouwer F. (2006) Depression as a risk factor for the onset of type 2 diabetes mellitus. A meta-analysis. Diabetologia; 49: 837–845

  2006cited by this paper
• Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action

  2006cited by this paper
• The Hypothalamic Neuropeptide Melanin-Concentrating Hormone Acts in the Nucleus Accumbens to Modulate Feeding Behavior and Forced-Swim Performance

  2005cited by this paper
• Body weight is regulated by the brain: a link between feeding and emotion

  2005cited by this paper
• Brain-Derived Neurotrophic Factor and Antidepressant Drugs Have Different But Coordinated Effects on Neuronal Turnover, Proliferation, and Survival in the Adult Dentate Gyrus

  2005cited by this paper
• Brain-derived neurotrophic factor Val66met polymorphism and volume of the hippocampal formation

  2005cited by this paper
• Deep brain stimulation for treatment-resistant depression.

  2005cited by this paper
• Reversal of Maternal Programming of Stress Responses in Adult Offspring through Methyl Supplementation: Altering Epigenetic Marking Later in Life

  2005cited by this paper
• Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication.

  2005cited by this paper
• Signal transduction abnormalities in melancholic depression.

  2005cited by this paper
• Neurotrophin levels in postmortem brains of suicide victims and the effects of antemortem diagnosis and psychotropic drugs.

  2005cited by this paper
• Focus on protein kinase A and protein kinase C, critical components of signal transduction system, in mood disorders and suicide.

  2005cited by this paper
• Environmental programming of stress responses through DNA methylation: life at the interface between a dynamic environment and a fixed genome

  2005cited by this paper
• Mood disorders in the medically ill: scientific review and recommendations.

  2005cited by this paper
• The pathogenesis of clinical depression: stressor- and cytokine-induced alterations of neuroplasticity.

  2005influential reference
• Hypercortisolemia and depression.

  2005influential reference
• Material for Alterations in 5-HT 1 B Receptor Function by p 11 in Depression-Like States

  2005cited by this paper
• Stress and the brain: from adaptation to disease

  2005cited by this paper
• Contributions of the amygdala to emotion processing: from animal models to human behavior.

  2005cited by this paper
• The interaction of stressful life events and a serotonin transporter polymorphism in the prediction of episodes of major depression: a replication.

  2005cited by this paper
• Cytokines as mediators of depression: what can we learn from animal studies?

  2005cited by this paper
• Thyroid and adrenal axis in major depression: a controlled study in outpatients.

  2005cited by this paper
• The negative immunoregulatory effects of fluoxetine in relation to the cAMP-dependent PKA pathway.

  2005cited by this paper
• Maternal programming of steroid receptor expression and phenotype through DNA methylation in the rat.

  2005cited by this paper
• Decreased Serotonin 5-HT2A Receptor-Stimulated Phosphoinositide Signaling in Fibroblasts from Melancholic Depressed Patients

  2004cited by this paper
• The phenomenology and treatment of interferon-induced depression.

  2004cited by this paper
• Risk and resilience in posttraumatic stress disorder.

  2004cited by this paper
• Association of depression with medical illness: does cortisol play a role?

  2004cited by this paper
• Protein kinase A in postmortem brain of depressed suicide victims: altered expression of specific regulatory and catalytic subunits.

  2004cited by this paper
• Importance of Studying the Contributions of Early Adverse Experience to Neurobiological Findings in Depression

  2004cited by this paper
• Epigenetics in human disease and prospects for epigenetic therapy

  2004cited by this paper
• Drug-Induced Decrease of Protein Kinase A Activity Reveals Alteration in BDNF Expression of Bipolar Affective Disorder

  2004cited by this paper

• Bidirectional Mendelian Randomization and Colocalization Study of Memory B Cells and Major Depressive Disorder

  2026cites this paper
• Leveraging topological indices and machine learning for advanced prediction of antidepressant drug properties

  2026cites this paper
• A modified tail suspension test for the assessment of behavioral despair in mice after stroke.

  2026cites this paper
• A review of neurophysiological relationships between sleep disorders and depression

  2026cites this paper
• Application of a Spatiotemporally Controlled Multiplex Microfluidic Electrochemical Sensor in the Detection of Antidepressant Drug and Depression Markers

  2026cites this paper
• Adenosine A2A receptors in the nucleus accumbens regulate stress resilience and predict susceptibility to stress-induced affective disturbances

  2026cites this paper
• Brain Neuroplasticity Mechanisms in Psychiatric Illnesses and in the Development of Novel Treatments.

  2026cites this paper
• Dual Stress Postischemia Deprivation Depression via Metabolic Disturbance in Rodents.

  2026cites this paper
• Multimodal Behavior Scoring quantifies depression-like severity across chronic stress models and identifies stress-resilient mice

  2026cites this paper
• p-Synephrine, synergistically with Gastrodin, alleviates reserpine-induced depressive pathologies by binding to MT1 receptor and activating ERK/CREB/BDNF pathway.

  2026cites this paper
• Translational assessment of butyrylcholinesterase activity as a diagnostic biomarker for depression using a chemiluminescent probe

  2026cites this paper
• Joint effects of exposure to polybrominated diphenyl ethers (PBDEs) and multiple metals on the risk of depression in adults.

  2026cites this paper
• Ventral tegmental area dopaminergic neurons mediate electroacupuncture relief of stress-induced depression in mice.

  2026cites this paper
• Targeting mGlyR with nanobodies for depression

  2026cites this paper
• Repeated adenosine A1 receptor antagonism rewires ventral hippocampus-ventral tegmental area transmission and enhances stress-coping responses.

  2026cites this paper
• Rising Stars: In vivo monitoring of neurochemical dynamics by genetically encoded neuromodulator sensors.

  2026cites this paper
• Distinct cytokine-producing dendritic cell profiles in females and males with major depressive disorder.

  2026cites this paper
• Decreased hippocampal neurogenesis and post-stroke depression

  2026cites this paper
• Treatment with perampanel alleviates depression-like behavior in mice via modulating GluN2B expression to improve excitatory synaptic transmission

  2026cites this paper
• Association between depression, nutritional status, and dietary intake in community-dwelling older adults: a cross-sectional analysis on baseline data of the Birjand longitudinal aging study (BLAS)

  2026cites this paper
• A Review of Related Research on Clinical Subtypes of Depression

  2026cites this paper
• Associations of depression with incident liver and spleen diseases: a retrospective cohort study

  2026cites this paper
• MicroRNA-129-5p in the mPFC is involved in the chronic mild stress-induced depression-like behaviors in rats.

  2026cites this paper
• Identification of antidepressant response-related changes to DNA methylation and gene expression

  2026cites this paper
• The Relationship Between Trace Elements and Depression

  2026cites this paper
• Toward personalized classification and treatment in depression: A narrative review of digital phenotyping and artificial intelligence.

  2026cites this paper
• Advances in aluminum oxide nanoparticles-induced neurotoxicity: CNS translocation, phenotypic outcomes, and mechanistic insights.

  2026cites this paper
• Aging reprograms the response to chronic stress

  2026cites this paper
• The synergistic effect of ambient PM2.5 and psychosocial stress on cardiac health: evidence from a multi-center panel study.

  2026cites this paper
• The synaptic triad in depression: how stress-related pathways converge on BDNF, NMDA receptor, and MMP-9.

  2026cites this paper
• Depression in mice causes decreased neuronal excitability and enhanced frequency adaptation in medial prefrontal cortex pyramidal neurons

  2025cites this paper
• Dysregulation of glutamatergic and GABAergic neurons in treatment-resistant depression: Insights from patient-derived neurons.

  2025cites this paper
• Hippocampal GPR17 down regulation ameliorates CMS-induced depression-like behaviors in mice.

  2025cites this paper
• Transcription factors Lef1 and Rest stimulate recovery from depressive states.

  2025cites this paper
• Sleep abnormalities in mouse models of depression: a systematic review.

  2025cites this paper
• The Association Between Violence Against Women and the Consumption of Addictive Substances in Mexico and the Role of Depression as a Mediator.

  2025cites this paper
• Transcriptional Profiling of D1-MSNs Reveals SIRT1-Dependent and -Independent Responses to Chronic Social Defeat Stress

  2025influential citation
• A Comprehensive Review of Nutritional Influences on the Serotonergic System

  2025cites this paper
• Superoxide Anion-Dependent Mitochondrial Fission Contributes to Hippocampal Synaptic Dysfunction in Stress-Susceptible Mice

  2025cites this paper
• Effects of MMP8 inhibitors on chronic unpredictable mild stress-induced neuroinflammation and depressive-like behavior：exploring the underlying molecular mechanisms.

  2025cites this paper
• Integrated Multi-Omics Analysis Reveals Immune and Metabolic Dysregulation in a Restraint Stress-Induced Depression Model

  2025cites this paper
• Novel insights into genetic associations and drug targets of mitochondria-associated proteins with major depressive disorder.

  2025cites this paper
• Frontiers and Opportunities in Visualization for Biomedical Research

  2025influential citation
• Rapid‐Onset Therapeutic Effects of Delta Opioid Receptor Agonists on Depression‐Like Behaviors Induced by Chronic Social Defeat Stress

  2025cites this paper
• Environmental Carcinogenesis: Nitric Oxide Release after Photodecomposition of Nitrosocontaminants in Drugs (Under UV Exposure) as Substantial Factor for Skin Carcinogenicity. Sertraline Induced Cutaneous Melanoma - Third Reported Case in Scientific Liter

  2025cites this paper
• What role does salt play in depression and anxiety? A prospective cohort study.

  2025cites this paper
• Depression Scores before and after Electrocompulsive Therapy with Propofol versus Ketamine Anesthesia: A Prospective Observational Study

  2025cites this paper
• Dysfunctional circular RNA network in major depressive disorder: dissecting the cell identity and potential clinical applications

  2025cites this paper
• Two subtypes of major depressive disorder are identified from individualized gray matter morphological abnormalities in a large multi-site dataset

  2025cites this paper
• Prevalence of Anxiety and Depression Symptoms Among Patients With Inflammatory Bowel Disease: A Multicenter Study

  2025cites this paper
• Unlocking ferulic acid for neurological diseases and tailoring of nanoformulations to advance its brain delivery.

  2025cites this paper
• Phlorizin Alleviates Depression-like Behaviors via Gut Microbiota Reprogramming-Induced Methionine to Inhibit Neuroinflammation in Mice Hippocampus

  2025cites this paper
• Elucidating the Mechanism of Emodin in Treating Post‐Stroke Depression Through Network Pharmacology and Animal Experiments

  2025cites this paper
• Updated meta-analysis of circulating glial cell line-derived neurotrophic factor levels in major depressive disorder: Clarifying case-control differences and treatment effects.

  2025cites this paper
• Isoacteoside alleviates LPS-induced depressive-like behaviors in mice by inhibiting neuroinflammation through regulating microglial polarization and oxidative stress

  2025cites this paper
• Psychological symptoms and resilience among former frontline healthcare workers against COVID-19: Insights from network analysis.

  2025cites this paper
• Posttranslational regulation of CREB-binding protein expression by F-box leucine-rich repeat-containing protein 19 and ubiquitin-specific peptidase 14 in the paraventricular nucleus participates in chronic stress-induced symptomatology via the modulation of the hypothalamic‒pituitary‒adrenal axis

  2025influential citation
• Unveiling the dual role of CD3G: a diagnostic biomarker for depression and its oncogenic implications

  2025cites this paper
• Association between daily dietary intake trajectory and depressive symptom onset and transition among young adults: a longitudinal study

  2025cites this paper
• From trauma to depression: structural, synaptic, epigenetic, and molecular pathways linking early stress to lifelong vulnerability

  2025cites this paper
• A molecular convergence in the triad of parkinson’s disease, depressive disorder and gut health is revealed by the inflammation-miRNA axis

  2025cites this paper
• Extracellular vesicles-mediated delivery of bumetanide alleviates depressive-like behaviors of male mice via restoring chloride homeostasis.

  2025cites this paper
• Prophylactic administration of Xuesaitong soft capsule ameliorating depression-like behaviors in rats after ischemic stroke by modulating metabolic disturbance.

  2025cites this paper
• Cathepsin B deficiency disrupts cortical development via PEG3, leading to depression-like behavior

  2025cites this paper
• Changes in astrocyte function induced by stress-induced glucocorticoid exacerbate major depressive disorder.

  2025cites this paper
• The effects of berberine on depressive symptoms: a systematic review and meta-analysis of preclinical studies

  2025cites this paper
• Antidepressant effects of fluoxetine: upregulation of connexin 36 and 43 in the hippocampus, prefrontal cortex, and amygdala

  2025cites this paper
• Molecular insights into the bidirectional link between anxiety and COVID-19: a combined clinical and bioinformatics approach

  2025cites this paper
• Post stroke depression: pathogenesis and molecular mechanisms of natural product-based interventions

  2025cites this paper
• Antidepressant effects of ershiwei roudoukou pills and its active ingredient Macelignan: Multiple mechanisms involving oxidative stress, neuroinflammation and synaptic plasticity

  2025cites this paper
• Patofisiologi Biomedik Depresi: Tinjauan Komprehensif terhadap Mekanisme Neurobiologis

  2025cites this paper
• Advancing Antidepressive Agents: Drug Discovery and Polymer-Based Drug Delivery Systems for Improved Treatment Outcome

  2025cites this paper
• Stress Accelerates Depressive-Like Behavior through Increase of SPNS2 Expression in Tg2576 Mice

  2025cites this paper
• Novel mechanisms underlying rapid-acting antidepressants: ketamine-like compounds, neurosteroid GABAkines, and psychedelics.

  2025cites this paper
• The Current Status of Antidepressant Drugs and the Exploration of New Targets

  2025cites this paper
• Discovery of Rapid-Acting, Orally Available Antidepressants by Activating TrkB Signaling.

  2025cites this paper
• Prevalence of Depression and Its Associated Factors Among Patients Undergoing Substance Abuse Treatment at Rehabilitation Centres in Pokhara, Nepal

  2025cites this paper
• Decoding Depression: Insights into Molecular Biomarkers and Neuroimaging of Depression

  2025cites this paper
• Chronic exposure to bisphenol S is associated with antagonistic neurobehavioral transformation and cleaved caspase 3 induced neurodegeneration in zebrafish brain.

  2025cites this paper
• Rapid analysis in small-volume urine: Optimizing LC-MS/MS for free glucocorticoids.

  2025cites this paper
• Transcriptional characteristics of human brain alterations in major depressive disorder: A systematic review.

  2025cites this paper
• Pathogenesis of HIV-associated depression: contributing factors and underlying mechanisms

  2025cites this paper
• Vascular depression: A comprehensive exploration of the definition, mechanisms, and clinical challenges.

  2025cites this paper
• ND‐AMD: A Web‐Based Database for Animal Models of Neurological Disease With Analysis Tools

  2025cites this paper
• A Study of Sex Differences in the Biological Pathways of Stress Regulation in Mice

  2025cites this paper
• The Interplay of Chronic Stress and Cancer: Pathophysiology and Implications for Integrated Care

  2025cites this paper
• Childhood maltreatment and depression: mediating role of lifestyle factors, personality traits, adult traumas, and social connections among middle-aged and elderly participants

  2025cites this paper
• Astrocytic connexin43 in the medial prefrontal cortex regulates depressive- and anxiety-like behaviors via ATP release.

  2025cites this paper
• Neurobiological and therapeutic landmarks of depression associated with Alzheimer’s disease dementia

  2025cites this paper
• A Review of Treatment Modalities for Comorbid Neuropathic Pain and Depression.

  2025cites this paper
• The shallow water test (SWT) as a novel behavioral paradigm to measure anxiety- and despair-like states in zebrafish.

  2025cites this paper
• A review of nonhuman primate models of depressive disorder.

  2025cites this paper
• Neuro-modulatory targets of aggression, depression and suicidal behaviour.

  2025cites this paper
• Modern Concept of Depression Pathogenesis: The Contribution of I.P. Lapin’s Research Team

  2025cites this paper
• Relationship of Lifespan Physical Activity Engagement With Quality of Life in Community‐Dwelling Adults: A Retrospective Study

  2025cites this paper
• Salt-inducible kinase 1 and CREB-regulated transcription co-activator 1 in the paraventricular nucleus participate in the antidepressant-like mechanism of (2R, 6R)-hydroxynorketamine and (2S, 6S)-hydroxynorketamine in mice.

  2025cites this paper
• Molecular Windows into the Brain: Advances in BBB-Penetrable NIR Fluorescent Imaging Probes.

  2025cites this paper
• Actigraphy-based step analysis for the detection of depressed mood: An explainable machine learning approach.

  2025cites this paper
• Pemafibrate treatment produces antidepressant-like effects in CUMS and CRS models through activation of hippocampal PPARα and BDNF signaling

  2025influential citation
• Neuroprotection vs. Neurotoxicity: The Dual Impact of Brain Lipids in Depression

  2025cites this paper